Pediatric Enteral Feeding Intolerance: A New Prognosticator for Children with Life-Limiting Illness?

2009 ◽  
Vol 25 (3) ◽  
pp. 213-217 ◽  
Author(s):  
Harold Siden ◽  
Tara Tucker ◽  
Sarah Derman ◽  
Kelly Cox ◽  
Gordon S. Soon ◽  
...  
1989 ◽  
Vol 13 (1) ◽  
pp. 38-46 ◽  
Author(s):  
William L. Meadow ◽  
Kim-Chi Bui ◽  
Elene Strates ◽  
Roger Dean

2019 ◽  
Vol 45 (7) ◽  
pp. 1029-1031 ◽  
Author(s):  
Yaseen M. Arabi ◽  
Annika Reintam Blaser ◽  
Jean-Charles Preiser

2019 ◽  
Author(s):  
Changjie Ren ◽  
Bo Yao ◽  
Miao Tuo ◽  
Hui Lin ◽  
Xiangyu Wan ◽  
...  

Abstract Objective: The goal of this study is to compare sequential feeding and continuous feeding on blood glucose of critically ill patients. Methods: A non-inferiority randomized controlled trail was adopted in this study. A total of 62 patients were finally enrolled, who were fed with enteral nutritional suspension through gastric tubes. After achieving 80% of the nutrition target calories (25kcal/kg/d) through continuous feeding, the patients were then randomly assigned into sequential feeding and continuous feeding group. In sequential feeding group, the feeding/fasting time was reasonably determined, according to the circadian rhythm of the human body in traditional Chinese medicine theory. The total daily dosage of enteral nutritional suspension was equally distributed to the three time periods of 7-9 o 'clock, 11-13 o 'clock and 17-19 o 'clock. Enteral nutritional suspension in each time period was pumped at a uniform rate within two hours by enteral feeding pump. While in continuous feeding group, patients received continuous feeding with constant velocity by enteral feeding pump during the study. Blood glucose values at 5 points (6:00/11:00/15:00/21:00/1:00) were monitored and recorded in 7 consecutive days after randomization. Meanwhile, enteral feeding intolerance was also recorded. Results: No significant demographic or physiologic differences between the sequential feeding and continuous feeding group (P >0.05). The average of glucose in sequential feeding was no inferior to continuous feeding [8.8(7.3-10.3) mmol/L vs. 10.7(9.1-12.1) mmol/L, P for non-inferiority =0.038). Hyperglycemia in CF group was more often than SF group (36.1% vs. 23.0%, P<0.01). There was no significant differences in glucose standard deviations and Glucosemax -Glucosemin between two groups (P>0.05). But the coefficient of glucose variation in sequential feeding group was higher than continuous feeding group [24.5(22.2-27.6) % vs. 18.9(13.7-25.3) %, P=0.013). Moreover, no significant difference in the incidence of feeding intolerance during the 7 days were found (P> 0.05). Conclusions: In this non-inferiority study, average blood glucose value of critically ill patients with sequential feeding was not higher than continuous feeding. And the feeding intolerance in sequential feeding was similar to continuous feeding.


2017 ◽  
Vol 22 (2) ◽  
pp. 112-117
Author(s):  
Meghan K. Belden ◽  
Sarah Gnadt ◽  
Ann Ebert

OBJECTIVE To determine whether antenatal exposure to magnesium sulfate has an effect on neonatal enteral feeding tolerance. METHODS In this single-center, retrospective, observational study, charts of pregnant women who received intravenous magnesium sulfate infusions prior to delivery between July 1, 2012, and July 31, 2013, were reviewed. Neonates born at 24 weeks' gestational age or greater admitted to the neonatal intensive care unit (NICU) whose mothers received magnesium sulfate infusions prior to delivery were included. Neonates with independent factors that could lead to feeding intolerance were excluded. The primary outcome was incidence of neonatal enteral feeding intolerance measured by deviations from the NICU feeding protocol. Secondary outcomes included days on parenteral nutrition, incidence of necrotizing enterocolitis, time to first stool, and urine output in the first 72 hours of life. RESULTS Cumulative maternal magnesium sulfate dose was significantly higher in the enteral feeding intolerance group than those infants who tolerated enteral feeds (70.4 ± 52.3 vs 47.4 ± 40.1 g; p = 0.04). Infants exposed to more than 80 g of maternal magnesium sulfate therapy were more likely to develop enteral feeding intolerance (44% vs 22%; p = 0.04). Multivariate logistic regression indicated that prematurity and cumulative maternal magnesium sulfate dose were the strongest predictors of neonatal enteral feeding intolerance. CONCLUSIONS Infants of mothers who received more than 80 g of intravenous magnesium sulfate prior to delivery were more likely to develop feeding intolerance. Prematurity also was a significant predictor of intolerance.


2017 ◽  
Vol 38 (8) ◽  
pp. 816-825 ◽  
Author(s):  
Lei Xu ◽  
Ting Wang ◽  
Ting Chen ◽  
Wen-Qun Yang ◽  
Ze-Ping Liang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document